Physician profile
Elbert A White
NPI 1811954324
$3,478.02
in general payments reported to CMS, 2019-2025
12 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,218 · 2022: $1,770 · 2023: $127 · 2024: $212 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $489.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $489.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,102.83 | 2019-2024 | N/A, Airo |
| Globus Medical, INC. | $985.20 | 2019 | |
| Cerapedics INC. | $83.36 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Providence Medical Technology, INC. | $80.55 | 2024-2025 | |
| Biocomposites INC | $49.83 | 2023 | Stimulan |
| Csl Behring | $35.88 | 2025 | Kcentra |
| Spineology INC. | $32.09 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $29.33 | 2023-2024 | Andexxa |
| Kerecis Limited | $29.11 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Medtronic, INC. | $18.29 | 2024 | Intellis Adaptivestim |
| Vertex Pharmaceuticals Incorporated | $17.51 | 2025 | |
| Intrinsic Therapeutics | $14.04 | 2023 | Barricaid Acd (Annular Closure Device) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elbert White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.